A strange symptom during his daily commute led to a man’s Stage IV cancer diagnosis
Joe Gillette’s daily routine took a drastic turn when his morning commute became a four-lane highway instead of the usual three lanes. It was during this drive that he noticed he was experiencing double vision out of one eye. Concerned that this may be a side effect of a recent battle with COVID-19, Gillette wasted no time in booking an appointment with his doctor.
Upon visiting his physician, Gillette was advised to consult with an eye specialist and undergo a brain scan. The specialist diagnosed nerve damage in his right eye, which explained the double vision. Despite this diagnosis, Gillette proceeded with the brain scan as a precaution. This decision turned out to be life-changing.
On his 57th birthday, Gillette received a notification on his online patient portal revealing devastating news – he had Stage IV kidney cancer. Further scans showed tumors in his lung, brain, stomach, bones, lymph nodes, lungs, and pancreas. Shocked and devastated, Gillette had unknowingly been living without any symptoms until his vision issues prompted further investigation.
Dr. Martin Voss, Gillette’s oncologist at Memorial Sloan Kettering Cancer Center, described his condition as dire. With less than a 20% survival rate for Stage IV kidney cancer patients, the road ahead was challenging. Gillette underwent aggressive treatment including immunotherapy, radiation, and brain surgery that required a 10-week medically induced coma for recovery.
Waking up from the coma, Gillette was disoriented to find out that months had passed. He underwent physical and occupational therapy to regain his strength before receiving more radiation therapy. The treatment proved effective as Gillette’s tumors began to shrink. Subsequent surgeries and two years of immunotherapy followed, with positive results and minimal side effects.
In April 2024, Gillette underwent surgery to remove the original kidney tumor, which surprisingly had a smooth recovery process. Regular check-ups, MRIs, and endoscopies are now part of Gillette’s routine to monitor for any new developments. His care team remains vigilant in keeping the cancer in check.
Despite the challenges, Gillette remains grateful for each day. He continues his oral immunotherapy, regular visits with Dr. Voss, and stays connected with other cancer survivors through volunteering with the American Cancer Society. Family milestones and a positive outlook on life keep Gillette focused on the present and hopeful for the future.
Through innovative treatment options and constant monitoring, Gillette’s journey with cancer serves as a testament to the importance of early detection and comprehensive care. His story is a reminder of the resilience and strength that can be found in the face of adversity.
